跳至主要内容
临床试验/DRKS00032613
DRKS00032613招募中Unknown

Surgery as needed versus surgery on principle in patients with postneoadjuvant clinical complete tumor response of esophageal cancer - ESORES-Trial

niversitätsklinikum Schleswig-Holstein, Campus Lübeck0 个研究点目标入组 670 人开始时间: 2023年9月27日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
670

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Key inclusion criteria:
  • EC (adenocarcinoma (EAC) and squamous cell carcinoma (ESCC)) according to the UICC definition (TNM8),
  • TNM stage: ycT0-3 ycN0 ycM0,
  • completion of neoadjuvant chemotherapy or neoadjuvant chemoradiation
  • no visible lymphatic or distant metastasis in routine postneoadjuvant CT,
  • ECOG Performance status 0-2
  • Age = 18 years

排除标准

  • Key exclusion criteria:
  • Postneoadjuvant dysphagia
  • Tumors of the cervical esophagus
  • Tumors with direct proximity to the membranous part of the central airway
  • TNM stage cT4 or ycT4
  • TNM stage cM1 or ycM1
  • Postneoadjuvant esophageal obstruction
  • Local tumor progression during/after neoadjuvant therapy detected by endoscopy or cross-sectional imaging
  • Time since last day of neoadjuvant anti-cancer treatment
  • Co-morbidity with contraindication for major surgery
  • nCRT with >50 Gy radiation dose

研究者

发起方
niversitätsklinikum Schleswig-Holstein, Campus Lübeck

相似试验